MRNA today
$241.10-$7.59 (-3.05%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minLeaning Bullish
5 minBearish
Daily trend turns down below $179.53
Key levels
Resistance$280.80
Resistance$254.48
Support$227.46
Support$204.70
Latest news & SEC filings
NewsModerna outlines strategic shift toward oncology and production upgrades at analyst day
NewsModerna presents growth strategy and pipeline updates at 2026 analyst day
GuidanceModerna lifts fiscal 2026 revenue outlook, now sees 15%-25% growth
AnalystArgus raises Moderna price target to $280 from $180
ProductModerna reports real-world data on mNEXSPIKE vaccine published
All MRNA news →About Moderna
Moderna is a biotechnology company that develops medicines based on messenger RNA technology. Its commercial products are vaccines for COVID-19, sold as Spikevax and mNEXSPIKE, and for respiratory syncytial virus, sold as mRESVIA. The company also runs clinical programs in infectious disease, oncology and rare disease, including a personalized cancer therapy developed with Merck. It sells to healthcare providers and governments, primarily in the United States, Europe, Canada, the UK and Australia.
Based on the company's 10-K filed Feb 20, 2026.
Nasdaq · Healthcare
Moderna, Inc. (MRNA)
What Is the Price Target for MRNA?
SEPT Low Target
$34.00
SEPT Mid Target
$81.00
SEPT High Target
$305.00
Analyst Consensus
$81.00
Is MRNA a Buy or Sell Right Now?
Thesis
- •Revenue growing -39.9% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MRNA.
Start Free Trial →Is MRNA Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$71.01
25
Moat Score
NONE
2/9
Piotroski Score
16.5
Altman Z-Score
What Is Smart Money Doing with MRNA?
Insider Signal
NEUTRAL
0 buys / 3 sells (90d)
Congress Signal
BUYING
4 buys / 4 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Hoge Stephen | officer | Buy | 76,452 | $933K | Oct 15, 2026 |
| Hoge Stephen | officer | Sale | 39,145 | $8.6M | Oct 15, 2026 |
| Hoge Stephen | officer | Buy | 76,453 | $933K | Oct 14, 2026 |
| Hoge Stephen | officer | Sale | 38,774 | $8.3M | Oct 14, 2026 |
| Hoge Stephen | officer | Sale | 450 | $96K | Oct 14, 2026 |
| Mock James M | officer | Buy | 1,454 | - | Oct 5, 2026 |
| Mock James M | officer | Sale | 704 | $134K | Oct 5, 2026 |
| Mock James M | officer | Buy | 11,797 | - | Sep 4, 2026 |
| Mock James M | officer | Sale | 5,704 | $849K | Sep 4, 2026 |
| Klinger Shannon Thyme | officer | Buy | 11,797 | - | Sep 4, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MRNA Growth Story
Revenue YoY
-39.9%
3yr Revenue CAGR
-53.4%
EPS Growth YoY
21.77%
FCF Growth YoY
49.1%
Revenue Trend
ACCELERATING
Dark Pool Trades for MRNA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MRNA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:13:55 | $241.06 | 1,000 | $$241K | BUY |
| 16:12:27 | $241.35 | 1,900 | $$459K | MIDPOINT |
| 15:54:49 | $239.70 | 1,100 | $$264K | SELL |
| 15:49:55 | $238.82 | 1,400 | $$334K | BUY |
| 15:45:11 | $237.69 | 1,000 | $$238K | BUY |
5 dark pool trades shown · $$1.5M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for MRNA
PREVIEWSEPT Investing provides real-time options flow tracking for MRNA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $105 | Mar 19 | 127 | $$1275 | 5 | SWEEP |
| PUT | $200 | Jun 17 | 217 | $$3555 | 1 | SWEEP |
| CALL | $115 | Dec 17 | 400 | $$726.1K | 50 | BLOCK |
| CALL | $180 | Jan 19 | 799 | $$644.9K | 50 | BLOCK |
| PUT | $220 | Nov 13 | 1 | $$62 | 1 | SWEEP |
5 options trades shown · 40% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About MRNA
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for MRNA. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Zone Setup -- $MRNA (Moderna, Inc.) Price: $79.76 | Zone: $73.68 to $81.40 Conviction: HIGH | Analyst upside: +-38.6% Major volume event today — setup forming. Strong positive news (5+ vs 0-)
Join 3,500+ traders discussing MRNA in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Moderna, Inc. (MRNA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MRNA — frequently asked questions
What is MRNA stock price today?
Moderna, Inc. (MRNA) is at $241.10, down 3.05% (-$7.59) at the Nov 12, 2026 close.
Why is MRNA stock moving today?
Latest MRNA news — Nov 12, 2026: Moderna outlines strategic shift toward oncology and production upgrades at analyst day · Nov 12, 2026: Moderna presents growth strategy and pipeline updates at 2026 analyst day
Why did MRNA stock move on Nov 6, 2026?
Moderna shares rose 3.58% to close at $254.19 after the company reported a surprise profit and raised its full-year revenue outlook during its Q3 2026 earnings call. The stock traded in a wide range on the day, hitting a high of $267.50 and a low of $237.86 on volume of over 14.2 million shares.
What is the MRNA price target?
The average analyst price target for MRNA is $81.00, ranging from $34 to $305, based on 13 analysts. Latest: Goldman Sachs maintains on Nov 9, 2026.
What do analysts rate MRNA?
Analyst ratings for MRNA: 3 Buy, 24 Hold, 5 Sell — consensus Hold.
Did MRNA beat earnings?
MRNA last reported on Nov 6, 2026: EPS $0.38 vs -$1.10 expected — a beat of 134.5%.
Does MRNA pay a dividend?
MRNA does not currently pay a dividend.
What are MRNA support and resistance levels?
Support: $227.46, $204.70, $179.53. Resistance: $254.48, $280.80, $321.35.
What are insiders doing with MRNA?
Insider activity: NEUTRAL, 0 buys and 3 sells in the last 90 days.
What is the latest news on MRNA?
Nov 12, 2026: Moderna outlines strategic shift toward oncology and production upgrades at analyst day · Nov 12, 2026: Moderna presents growth strategy and pipeline updates at 2026 analyst day · Nov 12, 2026: Moderna lifts fiscal 2026 revenue outlook, now sees 15%-25% growth